These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28716794)

  • 41. Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009.
    Phillips CJ; Woolpert T; Sevick C; Faix D; Blair PJ; Crum-Cianflone NF
    Clin Infect Dis; 2013 Jan; 56(1):11-9. PubMed ID: 23183869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.
    Tennis P; Toback SL; Andrews E; McQuay LJ; Ambrose CS
    Vaccine; 2011 Jul; 29(31):4947-52. PubMed ID: 21596087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study.
    Rose MA; Damm O; Greiner W; Knuf M; Wutzler P; Liese JG; Krüger H; Wahn U; Schaberg T; Schwehm M; Kochmann TF; Eichner M
    BMC Infect Dis; 2014 Jan; 14():40. PubMed ID: 24450996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.
    Chung JR; Flannery B; Thompson MG; Gaglani M; Jackson ML; Monto AS; Nowalk MP; Talbot HK; Treanor JJ; Belongia EA; Murthy K; Jackson LA; Petrie JG; Zimmerman RK; Griffin MR; McLean HQ; Fry AM
    Pediatrics; 2016 Feb; 137(2):e20153279. PubMed ID: 26738884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine.
    Shim E; Brown ST; DePasse J; Nowalk MP; Raviotta JM; Smith KJ; Zimmerman RK
    Am J Prev Med; 2016 Sep; 51(3):309-17. PubMed ID: 27079638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Sep; 33(38):4910-5. PubMed ID: 26232348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Cole KS; Martin JM; Horne WT; Lin CJ; Nowalk MP; Alcorn JF; Zimmerman RK
    Vaccine; 2017 Dec; 35(49 Pt B):6893-6897. PubMed ID: 29132989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children.
    Heikkinen T; Block SL; Toback SL; Wu X; Ambrose CS
    Pediatr Infect Dis J; 2013 Jun; 32(6):669-74. PubMed ID: 23271441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
    Muller-Pebody B; Sinnathamby MA; Warburton F; Rooney G; Andrews N; Whitaker H; Henderson KL; Tsang C; Hopkins S; Pebody RG
    Vaccine; 2021 Oct; 39(45):6622-6627. PubMed ID: 34627625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.
    Nordin JD; Vazquez-Benitez G; Olsen A; Kuckler LC; Gao AY; Kharbanda EO
    Vaccine; 2019 Jul; 37(30):4055-4060. PubMed ID: 31196683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere.
    Pebody R; McMenamin J; Nohynek H
    Arch Dis Child; 2018 Jan; 103(1):101-105. PubMed ID: 28855230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.
    Pitisuttithum P; Boonnak K; Chamnanchanunt S; Puthavathana P; Luvira V; Lerdsamran H; Kaewkungwal J; Lawpoolsri S; Thanachartwet V; Silachamroon U; Masamae W; Schuetz A; Wirachwong P; Thirapakpoomanunt S; Rudenko L; Sparrow E; Friede M; Kieny MP
    Lancet Infect Dis; 2017 Aug; 17(8):833-842. PubMed ID: 28533093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Gallagher N; Sinnathamby M; Yonova I; Correa A; Moore C; Sartaj M; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2017 Nov; 22(44):. PubMed ID: 29113630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)?
    Merckx J; McCormack D; Quach C
    Vaccine; 2016 Feb; 34(6):750-6. PubMed ID: 26752064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16.
    Pebody RG; Sinnathamby MA; Warburton F; Andrews N; Boddington NL; Zhao H; Yonova I; Ellis J; Tessier E; Donati M; Elliot AJ; Hughes HE; Pathirannehelage S; Byford R; Smith GE; de Lusignan S; Zambon M
    Euro Surveill; 2018 Jun; 23(25):. PubMed ID: 29945698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study.
    Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M;
    BMJ; 2015 Dec; 351():h6291. PubMed ID: 26645895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in Influenza Vaccination Rates After Withdrawal of Live Vaccine.
    Robison SG; Dunn AG; Richards DL; Leman RF
    Pediatrics; 2017 Nov; 140(5):. PubMed ID: 28986441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15.
    Pebody RG; Green HK; Andrews N; Boddington NL; Zhao H; Yonova I; Ellis J; Steinberger S; Donati M; Elliot AJ; Hughes HE; Pathirannehelage S; Mullett D; Smith GE; de Lusignan S; Zambon M
    Euro Surveill; 2015; 20(39):. PubMed ID: 26537222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.